Search
The SNO Lifetime Achievement Award is given annually to a meritorious individual who has made significant contributions in neuro-oncology over their career in clinical care and/or translational or basic research.
With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31–June 4, in Chicago.
Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.
Researchers from MSK are leading the effort to develop artificial intelligence tools for the detection of the most serious form of skin cancer.
When we talk about cancer, we often speak about “battling” or “fighting” it, writes psychiatrist William Breitbart. But a more useful mindset may focus less on combat and more on bravery, especially the courage to live, love, and care, despite the disease.
As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, oncologists at Memorial Sloan Kettering Cancer Center (MSK) are urging patients to schedule cancer screenings and treatments now.
Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower gut microbiota diversity before having a transplant appear to be at higher risk for developing complications. These findings further support evidence that the connection between microbiota and outcomes starts before people begin the transplantation process. These findings were presented as part of the 2018 annual meeting of the American Society of Hematology (ASH) press program.